Application Nr Approved Date Route Status External Links
NDA209091 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Qtern (Dapagliflozin And Saxagliptin) Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Limitations Of Use Qtern Is Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis. Qtern Is A Sodium-Glucose Cotransporter 2 (Sglt2) Inhibitor And A Dipeptidyl Peptidase-4 (Dpp-4) Inhibitor Combination Product Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. (1) Limitations Of Use : Qtern Is Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments